Dr. Stuart S. Kaplan, MD

Dr. Kaplan practices at Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida.

Dr. Kaplan's NPI, 1437126521, was assigned on March 7, 2006. Dr. Kaplan graduated from George Washington University School of Medicine and Health Sciences in 1988. Dr. Kaplan holds Florida license ME66170.

Dr. Kaplan's primary practice is Mount Sinai Medical Center, at 4300 Alton Rd, Miami Beach, FL 33140 in Miami-Dade County. The practice phone is (305) 674-2121.

Dr. Kaplan's primary practice is Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida. Dr. Kaplan is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is Mount Sinai Medical Center. Dmand AI also links Dr. Kaplan to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaplan practices, 4 sites in all. Vendor and product names are available with a free account.

Diagnostic radiology is Dr. Kaplan's primary specialty in the NPI Registry, under taxonomy code 2085R0202X. Dr. Kaplan is board certified in diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Kaplan's licenses on file in 3 states: Florida, California and South Carolina.

CMS data shows 2,474 Medicare services from Dr. Kaplan across 14 procedure codes in 2024, for 1,156 Medicare patients. Medicare paid $88,004 for them.

CMS counts 1,156 Medicare patients who saw Dr. Kaplan in 2024. The largest group is 65 to 74, with 593 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 13% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kaplan's median patient age at 58, with 98% women.

In 2024, Dr. Kaplan wrote 28 Medicare Part D claims for 12 patients. 64% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $117 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kaplan for performance year 2024, reported individually. Dr. Kaplan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Kaplan, published from 2013 to 2020. 2020 was the busiest year, with 2. The most frequent topics are Breast Neoplasms, Carcinoma, Squamous Cell and Metaplasia. Dr. Kaplan has published most often in Pathol Int. Dr. Kaplan's most frequent co-authors are Fernando Collado-Mesa, MD, Robert Poppiti, MD and Sarah Alghamdi, MD.

CMS Open Payments shows 65 general payments to Dr. Kaplan from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Leica Microsystems Inc. paid the most, $12,503.

Dmand AI lists 1 award for Dr. Kaplan, most recently Fellow in 2012.

Dr. Kaplan graduated from George Washington University School of Medicine and Health Sciences in 1988.

Dr. Kaplan is in network with 2 carriers, including Excellus BlueCross BlueShield and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.